Publikationen | Dr. Naber

1. How to set up regional STEMI networks: a "Stent - Save a life!" initiative.

Candiello A, Alexander T, Delport R, Toth GG, Ong P, Snyders A, Belardi JA, Lee MKY, Pereira H, Mohamed A, Mayol J, Piek JJ, Wijns W, Baumbach A, Naber C.

EuroIntervention. 2022 Mar 18;17(16):1313-1317. doi: 10.4244/EIJ-D-21-00694.

PMID: 34387547

2. Stent-Save a Life international survey on the practice of primary percutaneous coronary intervention during the COVID-19 pandemic.

Pereira H, Naber C, Wallace S, Gabor T, Abdi S, Alekyan B, Alexander T, Artucio C, Batista I, Candiello A, Delport R, De Luca L, Erglis A, Farto-Abreu P, Huang WC, Kanakakis J, Lee M, Mohamed A, Orlić D, Orti P, Sobh M, Shokry K, Terzic I, Win K, Piek J.

Rev Port Cardiol. 2022 Mar;41(3):221-227. doi: 10.1016/j.repc.2021.04.006. Epub 2021 Dec 25.

PMID: 34975228 Free PMC article.

3. PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY.

Gragnano F, Heg D, Franzone A, McFadden EP, Leonardi S, Piccolo R, Vranckx P, Branca M, Serruys PW, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, Diletti R, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg PG, Jüni P, Windecker S, Valgimigli M.

Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):28-38. doi: 10.1093/ehjcvp/pvaa106.

PMID: 32941620

4. Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry.

Nicolas J, Guedeney P, Claessen BE, Mehilli J, Petronio AS, Sartori S, Lefèvre T, Presbitero P, Capranzano P, Iadanza A, Cao D, Chiarito M, Goel R, Roumeliotis A, Chandiramani R, Chen S, Sardella G, Van Mieghem NM, Sorrentino S, Meliga E, Tchétché D, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail GW, Ferrer-Gracia MC, Naber C, Kievit PC, Baber U, Sharma SK, Morice MC, Dangas GD, Chandrasekhar J, Chieffo A, Mehran R.

Catheter Cardiovasc Interv. 2021 Nov 15;98(6):E908-E917. doi: 10.1002/ccd.29807. Epub 2021 Jun 12.

PMID: 34117817

5. Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German-Austrian ABSORB RegIstRy.

Boeder NF, Kastner J, Mehilli J, Münzel T, Naber C, Neumann T, Richardt G, Schmermund A, Wöhrle J, Zahn R, Riemer T, Achenbach S, Hamm CW, Nef HM; GABI-R Study Group.

Catheter Cardiovasc Interv. 2021 Oct;98(4):E555-E563. doi: 10.1002/ccd.29829. Epub 2021 Jun 18.

PMID: 34143547

6. Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry.

Tröbs M, Achenbach S, Nef HM, Gori T, Naber C, Neumann T, Richardt G, Schmermund A, Wöhrle J, Zahn R, Hamm CW; GABI-R Study Group.

Catheter Cardiovasc Interv. 2021 Oct;98(4):E564-E570. doi: 10.1002/ccd.29831. Epub 2021 Jun 17.

PMID: 34137482

7. Evaluation of Guideline Adherence for Cardiac Catheterization in Patients With Presumed Obstructive Coronary Artery Disease in Germany (ENLIGHT-KHK) - A Multicentre, Prospective, Observational Study.

Seleznova Y, Wein B, Müller D, Naumann M, Bruder O, Steffen M, Windhövel U, Loeser S, Artmann J, Fritz T, Eckardt M, Stock S, Naber CK.

Cardiovasc Revasc Med. 2021 Oct;31:19-25. doi: 10.1016/j.carrev.2020.11.021. Epub 2020 Nov 28.

PMID: 33288463

8. Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry.

Nicolas J, Claessen BE, Cao D, Sartori S, Baber U, Power D, Chiarito M, Goel R, Roumeliotis A, Chandiramani R, Chen S, Chandrasekhar J, Tchetche D, Petronio AS, Mehilli J, Lefèvre T, Presbitero P, Capranzano P, Iadanza A, Sardella G, Van Mieghem NM, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail G, Ferrer-Gracia MC, Naber C, Sharma S, Morice MC, Dangas GD, Chieffo A, Mehran R.

Catheter Cardiovasc Interv. 2021 Apr 1;97(5):E704-E715. doi: 10.1002/ccd.29276. Epub 2020 Oct 1.

PMID: 33002302

9. Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Chieffo A, Tarantini G, Naber CK, Barbato E, Roffi M, Stefanini GG, Buchanan GL, Buszman P, Moreno R, Zawiślak B, Cayla G, Danenberg H, Da Silveira JAB, Nef H, James SK, Mauri Ferre J, Voskuil M, Witt N, Windecker S, Baumbach A, Dudek D.

EuroIntervention. 2021 Feb 19;16(14):1177-1186. doi: 10.4244/EIJ-D-20-01291.

PMID: 33416050

10. Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing TAVI for severe aortic stenosis: Insights from the WIN-TAVI registry.

Panoulas VF, Chandrasekhar J, Busi G, Ruparelia N, Zhang Z, Mehilli J, Sartori S, Lefèvre T, Presbitero P, Capranzano P, Tchetche D, Iadanza A, Sardella G, Van Mieghem NM, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Sharma S, Ferrer-Gracia MC, Naber CK, Kievit PC, Snyder C, Sutaria N, Sen S, Malik IS, Morice MC, Nihoyannopoulos P, Petronio AS, Mehran R, Chieffo A, Mikhail GW; WIN-TAVI Investigators.

Catheter Cardiovasc Interv. 2021 Feb 15;97(3):516-526. doi: 10.1002/ccd.29227. Epub 2020 Aug 31.

PMID: 32865860

11. Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY.

Leonardi S, Branca M, Franzone A, McFadden E, Piccolo R, Jüni P, Vranckx P, Steg PG, Serruys PW, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, Diletti R, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Heg D, Windecker S, Valgimigli M.

Circ Cardiovasc Qual Outcomes. 2021 Feb;14(2):e006581. doi: 10.1161/CIRCOUTCOMES.120.006581. Epub 2021 Feb 4.

PMID: 33535773

12. Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry.

Goel R, Sartori S, Cao D, Claessen BE, Baber U, Chandiramani R, Nicolas J, Roumeliotis A, Power D, Chandrasekhar J, Tchetche D, Petronio AS, Mehilli J, Lefevre T, Presbitero P, Capranzano P, Iadanza A, Sardella G, Van Mieghem NM, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail GW, Ferrer-Gracia MC, Naber C, Sharma S, Morice MC, Dangas GD, Chieffo A, Mehran R.

Int J Cardiol. 2021 Jan 1;322:65-69. doi: 10.1016/j.ijcard.2020.08.035. Epub 2020 Aug 16.

PMID: 32814108

13. Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial.

Gao C, Buszman P, Buszman P, Chichareon P, Modolo R, Garg S, Takahashi K, Kawashima H, Wang R, Chang CC, Kogame N, Tomaniak M, Ono M, Hara H, Slagboom T, Aminian A, Naber CK, Carrie D, Hamm C, Steg PG, Onuma Y, Geuns RV, Serruys PW, Zurakowski A.

Can J Cardiol. 2021 Jan;37(1):122-130. doi: 10.1016/j.cjca.2020.01.029. Epub 2020 Feb 21.

PMID: 32450057 Clinical Trial.

14. Systematic investment in the delivery of guideline-coherent therapy reduces mortality and overall costs in patients with ST-elevation myocardial infarction: Results from the Stent for Life economic model for Romania, Portugal, Basque Country and Kemerovo region.

Wein B, Bashkireva A, Au-Yeung A, Yoculan A, Vinereanu D, Deleanu D, Pereira H, Pereira E, de Mello S, Rumoroso JR, Ganyukov V, Wijns W, Naber CK.

Eur Heart J Acute Cardiovasc Care. 2020 Dec;9(8):902-910. doi: 10.1177/2048872619853959. Epub 2019 Sep 26.

PMID: 31557050 Free PMC article.

15. Impact of coronary calcification on outcomes after ABSORB scaffold implantation: insights from the GABI-R registry.

Hemetsberger R, Abdelghani M, Mankerious N, Allali A, Toelg R, Gori T, Achenbach S, Riemer T, Mehilli J, Nef HM, Naber C, Wöhrle J, Zahn R, Kastner J, Schmermund A, Hamm C, Münzel T, Richardt G; GABI-R Study Group.

Coron Artery Dis. 2020 Nov;31(7):578-585. doi: 10.1097/MCA.0000000000000870.

PMID: 32271247

16. Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study).

Giacoppo D, Alfonso F, Xu B, Claessen BEPM, Adriaenssens T, Jensen C, Pérez-Vizcayno MJ, Kang DY, Degenhardt R, Pleva L, Baan J, Cuesta J, Park DW, Schunkert H, Colleran R, Kukla P, Jiménez-Quevedo P, Unverdorben M, Gao R, Naber CK, Park SJ, Henriques JPS, Kastrati A, Byrne RA.

Eur Heart J. 2020 Oct 7;41(38):3715-3728. doi: 10.1093/eurheartj/ehz594.

PMID: 31511862 Free PMC article.

17. The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry.

Bandyopadhyay D, Sartori S, Baber U, Cao D, Chandiramani R, Tchétché D, Petronio AS, Mehilli J, Lefèvre T, Presbitero P, Capranzaro P, Sardella G, Van Mieghem NM, Chandrasekhar J, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail GW, Naber C, Kini A, Morice MC, Claessen BE, Chieffo A, Mehran R.

Catheter Cardiovasc Interv. 2020 Jul;96(1):198-207. doi: 10.1002/ccd.28752. Epub 2020 Jan 24.

PMID: 31977142

18. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.

Giacoppo D, Alfonso F, Xu B, Claessen BEPM, Adriaenssens T, Jensen C, Pérez-Vizcayno MJ, Kang DY, Degenhardt R, Pleva L, Baan J, Cuesta J, Park DW, Kukla P, Jiménez-Quevedo P, Unverdorben M, Gao R, Naber CK, Park SJ, Henriques JPS, Kastrati A, Byrne RA.

J Am Coll Cardiol. 2020 Jun 2;75(21):2664-2678. doi: 10.1016/j.jacc.2020.04.006.

PMID: 32466881

19. Impact of Predilatation Prior to Transcatheter Aortic Valve Implantation With the Self-Expanding Acurate neo Device (from the Multicenter NEOPRO Registry).

Pagnesi M, Kim WK, Conradi L, Barbanti M, Stefanini GG, Schofer J, Hildick-Smith D, Pilgrim T, Abizaid A, Zweiker D, Testa L, Taramasso M, Wolf A, Webb JG, Sedaghat A, Van der Heyden JAS, Ziviello F, MacCarthy P, Hamm CW, Bhadra OD, Schäfer U, Costa G, Tamburino C, Cannata F, Reimers B, Eitan A, Alsanjari O, Asami M, Windecker S, Siqueira D, Schmidt A, Bianchi G, Bedogni F, Saccocci M, Maisano F, Jensen CJ, Naber CK, Alenezi A, Wood DA, Sinning JM, Brouwer J, Tzalamouras V, Van Mieghem NM, Colombo A, Latib A.

Am J Cardiol. 2020 May 1;125(9):1369-1377. doi: 10.1016/j.amjcard.2020.02.003. Epub 2020 Feb 8.

PMID: 32098656

20. Validation of the all-comers design: Results of the TARGET-AC substudy.

G Toth G, Lansky A, Baumbach A, Kelbæk H, van Royen N, Holmvang L, Janssens L, Brugaletta S, Barbato E, Maillard L, Kiemeneij F, Naber CK, Pucher F, Laursen PN, Ameloot K, Robles C, Milkas A, Sevilla J, Jensen C, Wijns W.

Am Heart J. 2020 Mar;221:148-154. doi: 10.1016/j.ahj.2019.10.019. Epub 2019 Nov 27.

PMID: 31924299

21. Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).

Giannini C, Petronio AS, Mehilli J, Sartori S, Chandrasekhar J, Faggioni M, Lefèvre T, Presbitero P, Capranzano P, Tchetche D, Iadanza A, Sardella G, Van Mieghem NM, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail GW, Ferrer MC, Naber C, Kievit P, Sorrentino S, Morice MC, Chieffo A, Mehran R; WIN-TAVI Investigators.

Am J Cardiol. 2020 Feb 1;125(3):441-448. doi: 10.1016/j.amjcard.2019.10.056. Epub 2019 Nov 9.

PMID: 31813530

22. Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting.

Franzone A, McFadden E, Leonardi S, Piccolo R, Vranckx P, Serruys PW, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, Diletti R, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg PG, Heg D, Jüni P, Windecker S, Valgimigli M; GLASSY Investigators.

J Am Coll Cardiol. 2019 Nov 5;74(18):2223-2234. doi: 10.1016/j.jacc.2019.08.1038.

PMID: 31672177 Clinical Trial.

23. Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes.

Oh TS, Le K, Baddour LM, Sohail MR, Vikram HR, Hernandez-Meneses M, Miro JM, Prutkin JM, Greenspon AJ, Carrillo RG, Danik SB, Naber CK, Blank E, Tseng CH, Uslan DZ, Peacock JE Jr; MEDIC (Multicenter Electrophysiologic Device Infection Cohort) Investigators.

Pacing Clin Electrophysiol. 2019 Oct;42(10):1331-1339. doi: 10.1111/pace.13783. Epub 2019 Sep 3.

PMID: 31424091

24. Feasibility of Transfemoral Aortic Valve Implantation in Patients With Aortic Disease and Simultaneous or Sequential Endovascular Aortic Repair.

Patsalis PC, Alotaibi S, Wolf A, Scholtz W, Kloppe A, Plicht B, Buck T, Haldenwang PL, Strauch JT, Nicolas V, Rudolph V, Mügge A, Naber CK.

J Invasive Cardiol. 2019 Oct;31(10):289-295. Epub 2019 Aug 15.

PMID: 31416046

25. 2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent.

Xu B, Saito Y, Baumbach A, Kelbæk H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina C, Buszman P, Thiele H, Schächinger V, Lansky A, Wijns W; TARGET AC Investigators.

JACC Cardiovasc Interv. 2019 Sep 9;12(17):1679-1687. doi: 10.1016/j.jcin.2019.05.001. Epub 2019 May 22.

PMID: 31129092 Clinical Trial.

26. Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial.

Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang CC, Tomaniak M, Asano T, Katagiri Y, van Geuns RM, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber CK, Sabaté M, Iqbal J, Wykrzykowska JJ, Piek JJ, Spitzer E, Jüni P, Hamm C, Steg PG, Valgimigli M, Vranckx P, Windecker S, Serruys PW.

EuroIntervention. 2019 Aug 9;15(6):e539-e546. doi: 10.4244/EIJ-D-19-00184.

PMID: 31217143 Clinical Trial.

27. Protocol of the China ST-segment elevation myocardial infarction (STEMI) Care Project (CSCAP): a 10-year project to improve quality of care by building up a regional STEMI care network.

Zhang Y, Yu B, Han Y, Wang J, Yang L, Wan Z, Zhang Z, Chen Y, Fu X, Gao C, Li B, Chen J, Wu M, Ma Y, Zhao X, Chen Y, Yan H, Xiang D, Fang W, Mehta S, Naber CK, Ge J, Huo Y.

BMJ Open. 2019 Jul 17;9(7):e026362. doi: 10.1136/bmjopen-2018-026362.

PMID: 31320346 Free PMC article.

28. Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-years Results from the GABI-R Registry.

Gori T, Achenbach S, Riemer T, Mehilli J, Nef HM, Naber C, Richardt G, Wöhrle J, Zahn R, Neumann T, Kastner J, Schmermund A, Hamm C, Münzel T.

J Clin Med. 2019 May 30;8(6):767. doi: 10.3390/jcm8060767.

PMID: 31151213 Free PMC article.

29. Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.

Guedeney P, Tchétché D, Petronio AS, Mehilli J, Sartori S, Lefèvre T, Presbitero P, Capranzano P, Iadanza A, Sardella G, Van Mieghem NM, Sorrentino S, Claessen BEPM, Chandrasekhar J, Vogel B, Kalkman DN, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail G, Ferrer-Grazia MC, Naber C, Kievit P, Baber U, Sharma S, Morice MC, Chieffo A, Mehran R; WIN TAVI Investigators.

Catheter Cardiovasc Interv. 2019 May 1;93(6):1124-1131. doi: 10.1002/ccd.28012. Epub 2018 Dec 4.

PMID: 30511802

30. Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) - Nice, France, 20-21 June 2018.

Barbato E, Mauri J, Byrne RA, Roffi M, Fitzsimons D, Toth G, Capodanno D, Mehilli J, Petronio AS, Chieffo A, Vardas P, Naber CK, Dudek D, Haude M, Baumbach A.

EuroIntervention. 2019 Apr 20;14(17):1720-1723. doi: 10.4244/EIJV14I17A297.

PMID: 31023642 No abstract available.

31. Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.

Pagnesi M, Kim WK, Conradi L, Barbanti M, Stefanini GG, Zeus T, Pilgrim T, Schofer J, Zweiker D, Testa L, Taramasso M, Hildick-Smith D, Abizaid A, Wolf A, Van Mieghem NM, Sedaghat A, Wöhrle J, Khogali S, Van der Heyden JAS, Webb JG, Estévez-Loureiro R, Mylotte D, MacCarthy P, Brugaletta S, Hamm CW, Bhadra OD, Schäfer U, Costa G, Tamburino C, Cannata F, Reimers B, Veulemans V, Asami M, Windecker S, Eitan A, Schmidt A, Bianchi G, Bedogni F, Saccocci M, Maisano F, Alsanjari O, Siqueira D, Jensen CJ, Naber CK, Ziviello F, Sinning JM, Seeger J, Rottbauer W, Brouwer J, Alenezi A, Wood DA, Tzalamouras V, Regueiro A, Colombo A, Latib A.

JACC Cardiovasc Interv. 2019 Mar 11;12(5):433-443. doi: 10.1016/j.jcin.2018.11.036.

PMID: 30846081

32. Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY).

Leonardi S, Franzone A, Piccolo R, McFadden E, Vranckx P, Serruys P, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, van Geuns RJ, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg G, Heg D, Juni P, Windecker S, Valgimigli M.

BMJ Open. 2019 Mar 9;9(3):e026053. doi: 10.1136/bmjopen-2018-026053.

PMID: 30852547 Free PMC article. Clinical Trial.

33. Impact of Discharge Location After Transcatheter Aortic Valve Replacement on 1-Year Outcomes in Women: Results From the WIN-TAVI Registry.

Mehilli J, Chandrasekhar J, Sartori S, Chieffo A, Petronio AS, Lefèvre T, Presbitero P, Capranzano P, Tchetche D, Iadanza A, Sardella G, Van Mieghem NM, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Jochheim D, Zadrozny M, Mikhail GW, Sharma S, Ferrer MC, Naber C, Kievit P, Moalem K, Baber U, Snyder C, Sharma M, Morice MC, Mehran R; Women’s INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) Investigators.

Can J Cardiol. 2019 Feb;35(2):199-207. doi: 10.1016/j.cjca.2018.11.035. Epub 2018 Dec 12.

PMID: 30760427

34. Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II.

Jeger RV, Pfisterer M, Vogt DR, Galatius S, Abildgaard U, Naber C, Alber H, Eberli F, Kurz DJ, Pedrazzini G, Vuilliomenet A, Weilenmann D, Rickli H, Hansen KW, Rickenbacher P, Conen D, Müller C, Osswald S, Gilgen N, Kaiser C.

PLoS One. 2019 Jan 15;14(1):e0210821. doi: 10.1371/journal.pone.0210821. eCollection 2019.

PMID: 30645635 Free PMC article.

35. Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).

Guedeney P, Chieffo A, Snyder C, Mehilli J, Petronio AS, Claessen BE, Sartori S, Lefèvre T, Presbitero P, Capranzano P, Tchétché D, Iadanza A, Sardella G, Van Mieghem NM, Chandrasekhar J, Vogel B, Sorrentino S, Kalkman DN, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail G, Ferrer MC, Naber C, Kievit P, Baber U, Sharma S, Morice MC, Mehran R; WIN-TAVI Investigators.

Am J Cardiol. 2018 Dec 1;122(11):1909-1916. doi: 10.1016/j.amjcard.2018.08.036. Epub 2018 Sep 8.

PMID: 30318417

36. Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trial.

Jensen CJ, Richardt G, Tölg R, Erglis A, Skurk C, Jung W, Neumann FJ, Stangl K, Brachmann J, Fischer D, Mehilli J, Rieber J, Wiemer M, Schofer J, Sack S, Naber CK.

EuroIntervention. 2018 Nov 20;14(10):1096-1103. doi: 10.4244/EIJ-D-17-01079.

PMID: 29808819 Clinical Trial.

37. Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial.

Lansky A, Wijns W, Xu B, Kelbæk H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina C, Buszman P, Thiele H, Schächinger V, Baumbach A; TARGET All Comers Investigators.

Lancet. 2018 Sep 29;392(10153):1117-1126. doi: 10.1016/S0140-6736(18)31649-0. Epub 2018 Sep 3.

PMID: 30190206 Clinical Trial.

38. Predictors of early scaffold thrombosis: results from the multicenter prospective German-Austrian ABSORB RegIstRy.

Wöhrle J, Nef HM, Naber C, Achenbach S, Riemer T, Mehilli J, Münzel T, Schneider S, Markovic S, Seeger J, Rottbauer W, Pfannebecker T, Richardt G, Zahn R, Gori T, Kastner J, Schmermund A, Hamm CW; GABI-R Study Group.

Coron Artery Dis. 2018 Aug;29(5):389-396. doi: 10.1097/MCA.0000000000000618.

PMID: 29649071

39. Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement.

Schmidt T, Leon MB, Mehran R, Kuck KH, Alu MC, Braumann RE, Kodali S, Kapadia SR, Linke A, Makkar R, Naber C, Romero ME, Virmani R, Frerker C.

JACC Cardiovasc Interv. 2018 Jul 9;11(13):1262-1273. doi: 10.1016/j.jcin.2018.03.001.

PMID: 29976363

40. Diagnostic Performance of In-Procedure Angiography-Derived Quantitative Flow Reserve Compared to Pressure-Derived Fractional Flow Reserve: The FAVOR II Europe-Japan Study.

Westra J, Andersen BK, Campo G, Matsuo H, Koltowski L, Eftekhari A, Liu T, Di Serafino L, Di Girolamo D, Escaned J, Nef H, Naber C, Barbierato M, Tu S, Neghabat O, Madsen M, Tebaldi M, Tanigaki T, Kochman J, Somi S, Esposito G, Mercone G, Mejia-Renteria H, Ronco F, Bøtker HE, Wijns W, Christiansen EH, Holm NR.

J Am Heart Assoc. 2018 Jul 6;7(14):e009603. doi: 10.1161/JAHA.118.009603.

PMID: 29980523 Free PMC article.

41. Attempted salvage of infected cardiovascular implantable electronic devices: Are there clinical factors that predict success?

Peacock JE Jr, Stafford JM, Le K, Sohail MR, Baddour LM, Prutkin JM, Danik SB, Vikram HR, Hernandez-Meneses M, Miró JM, Blank E, Naber CK, Carrillo RG, Greenspon AJ, Tseng CH, Uslan DZ.

Pacing Clin Electrophysiol. 2018 May;41(5):524-531. doi: 10.1111/pace.13319. Epub 2018 Apr 3.

PMID: 29518265

42. Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected.

Wijns W, Naber CK.

Eur Heart J. 2018 Apr 1;39(13):1075-1077. doi: 10.1093/eurheartj/ehy069.

PMID: 29452358 No abstract available.

43. Clinical presentation of CIED infection following initial implant versus reoperation for generator change or lead addition.

Harper MW, Uslan DZ, Greenspon AJ, Baddour LM, Carrillo RG, Danik SB, Tolosana JM, Le K, Miro JM, Naber CK, Peacock J Jr, Sohail MR, Vikram HR, Prutkin JM.

Open Heart. 2018 Mar 30;5(1):e000681. doi: 10.1136/openhrt-2017-000681. eCollection 2018.

PMID: 29632673 Free PMC article.

44. Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy.

Jensen CJ, Naber CK, Urban P, Ong PJ, Valdes-Chavarri M, Abizaid AA, Pocock SJ, Fabbiocchi F, Dubois C, Copt S, Stoll HP, Morice MC.

EuroIntervention. 2018 Mar 20;13(16):1946-1949. doi: 10.4244/EIJ-D-17-00720.

PMID: 29336310 Clinical Trial. No abstract available.

45. Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI).

Eggebrecht H, Vaquerizo B, Moris C, Bossone E, Lämmer J, Czerny M, Zierer A, Schröfel H, Kim WK, Walther T, Scholtz S, Rudolph T, Hengstenberg C, Kempfert J, Spaziano M, Lefevre T, Bleiziffer S, Schofer J, Mehilli J, Seiffert M, Naber C, Biancari F, Eckner D, Cornet C, Lhermusier T, Philippart R, Siljander A, Giuseppe Cerillo A, Blackman D, Chieffo A, Kahlert P, Czerwinska-Jelonkiewicz K, Szymanski P, Landes U, Kornowski R, D'Onofrio A, Kaulfersch C, Søndergaard L, Mylotte D, Mehta RH, De Backer O; European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI).

Eur Heart J. 2018 Feb 21;39(8):676-684. doi: 10.1093/eurheartj/ehx713.

PMID: 29253177

46. Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry.

Capranzano P, Capodanno D, Brugaletta S, Latib A, Mehilli J, Nef H, Gori T, Lesiak M, Geraci S, Pyxaras S, Mattesini A, Münzel T, Araszkiewicz A, Caramanno G, Naber C, Di Mario C, Sabatè M, Colombo A, Wiebe J, Tamburino C.

Catheter Cardiovasc Interv. 2018 Feb 15;91(3):444-453. doi: 10.1002/ccd.27388. Epub 2017 Oct 25.

PMID: 29068130

47. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.

Chieffo A, Petronio AS, Mehilli J, Chandrasekhar J, Sartori S, Lefèvre T, Presbitero P, Capranzano P, Tchetche D, Iadanza A, Sardella G, Van Mieghem NM, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail G, Sharma S, Ferrer MC, Naber C, Kievit P, Baber U, Snyder C, Sharma M, Morice MC, Mehran R; WIN-TAVI Investigators.

JACC Cardiovasc Interv. 2018 Jan 8;11(1):1-12. doi: 10.1016/j.jcin.2017.09.034.

PMID: 29301640

48. Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R).

Nef HM, Wiebe J, Kastner J, Mehilli J, Muenzel T, Naber C, Neumann T, Richardt G, Schmermund A, Woehrle J, Zahn R, Riemer T, Achenbach S, Hamm CW.

EuroIntervention. 2017 Dec 20;13(11):1311-1318. doi: 10.4244/EIJ-D-17-00330.

PMID: 28829745

49. Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R.

Mehilli J, Achenbach S, Woehrle J, Baquet M, Riemer T, Muenzel T, Nef H, Naber C, Richardt G, Zahn R, Gori T, Neumann T, Kastner J, Schmermund A, Hamm C.

EuroIntervention. 2017 Dec 20;13(11):1319-1326. doi: 10.4244/EIJ-D-17-00291.

PMID: 28649953

50. Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry.

Schnorbus B, Wiebe J, Capodanno D, Brugaletta S, Geraci S, Mehilli J, Latib A, Lesiak M, Jensen C, Mattesini A, Münzel T, Capranzano P, Di Mario C, Naber C, Araszkiewicz A, Colombo A, Caramanno G, Sabate M, Tamburino C, Nef H, Gori T.

EuroIntervention. 2017 Oct 13;13(9):e1104-e1111. doi: 10.4244/EIJ-D-16-00568.

PMID: 28320687

51. Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score.

Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S.

EuroIntervention. 2017 Apr 20;12(17):2110-2117. doi: 10.4244/EIJ-D-16-00974.

PMID: 28246060

52. Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.

Ortega-Paz L, Capodanno D, Giacchi G, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S.

Catheter Cardiovasc Interv. 2017 Apr;89(5):812-818. doi: 10.1002/ccd.26674. Epub 2016 Aug 12.

PMID: 27515568

53. Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study.

Naber CK, Urban P, Ong PJ, Valdes-Chavarri M, Abizaid AA, Pocock SJ, Fabbiocchi F, Dubois C, Copt S, Greene S, Morice MC; LEADERS FREE Investigators.

Eur Heart J. 2017 Apr 1;38(13):961-969. doi: 10.1093/eurheartj/ehw203.

PMID: 27190095 Free PMC article. Clinical Trial.

54. Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry.

Geraci S, Kawamoto H, Caramanno G, Ruparelia N, Capodanno D, Brugaletta S, Gori T, Nef H, Sabate M, Mehilli J, Lesiak M, Naber C, Di Mario C, Capranzano P, Wiebe J, Araszkiewicz A, Pyxaras S, Mattesini A, Münzel T, Tamburino C, Colombo A, Latib A.

JACC Cardiovasc Interv. 2017 Mar 27;10(6):560-568. doi: 10.1016/j.jcin.2016.12.013. Epub 2017 Mar 1.

PMID: 28259663

55. 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents.

Garot P, Morice MC, Tresukosol D, Pocock SJ, Meredith IT, Abizaid A, Carrié D, Naber C, Iñiguez A, Talwar S, Menown IBA, Christiansen EH, Gregson J, Copt S, Hovasse T, Lurz P, Maillard L, Krackhardt F, Ong P, Byrne J, Redwood S, Windhövel U, Greene S, Stoll HP, Urban P; LEADERS FREE Investigators.

J Am Coll Cardiol. 2017 Jan 17;69(2):162-171. doi: 10.1016/j.jacc.2016.10.009. Epub 2016 Oct 30.

PMID: 27806919 Clinical Trial.

56. Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry.

Naganuma T, Colombo A, Lesiak M, Capodanno D, Gori T, Nef H, Caramanno G, Naber C, Di Mario C, Ruparelia N, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Kawamoto H, Pyxaras S, Mattesini A, Münzel T, Tamburino C, Latib A.

Catheter Cardiovasc Interv. 2017 Jan;89(1):47-56. doi: 10.1002/ccd.26634. Epub 2016 Jul 14.

PMID: 27414021

57. A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis.

Naber CK, Pyxaras SA, Ince H, Frambach P, Colombo A, Butter C, Gatto F, Hink U, Nickenig G, Bruschi G, Brueren G, Tchétché D, Den Heijer P, Schillinger W, Scholtz S, Van der Heyden J, Lefèvre T, Gilard M, Kuck KH, Schofer J, Divchev D, Baumgartner H, Asch F, Wagner D, Latib A, De Marco F, Kische S.

EuroIntervention. 2016 Dec 10;12(11):e1413-e1419. doi: 10.4244/EIJ-D-15-00511.

PMID: 27934611 Clinical Trial.

58. Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry.

Capodanno D, Gargiulo G, Buccheri S, Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar RR, Palacios IF, Kim YH, Buszman PE, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Leon MB, Moses JW, Fajadet J, Lefèvre T, Morice MC, Erglis A, Alfieri O, Serruys PW, Colombo A, Tamburino C; DELTA Investigators.

JACC Cardiovasc Interv. 2016 Nov 28;9(22):2280-2288. doi: 10.1016/j.jcin.2016.08.025.

PMID: 27884354

59. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.

Chieffo A, Petronio AS, Mehilli J, Chandrasekhar J, Sartori S, Lefèvre T, Presbitero P, Capranzano P, Tchetche D, Iadanza A, Sardella G, Van Mieghem NM, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail GW, Sharma S, Ferrer MC, Naber C, Kievit P, Faggioni M, Snyder C, Morice MC, Mehran R; WIN-TAVI Investigators.

JACC Cardiovasc Interv. 2016 Aug 8;9(15):1589-600. doi: 10.1016/j.jcin.2016.05.015.

PMID: 27491609

60. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.

Pyxaras SA, Hunziker L, Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar RR, Palacios IF, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Margey R, Agnihotri A, Marra S, Capodanno D, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A, Naber CK.

EuroIntervention. 2016 Aug 5;12(5):e623-31. doi: 10.4244/EIJV12I5A102.

PMID: 27497362

61. Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry.

Gori T, Wiebe J, Capodanno D, Latib A, Lesiak M, Pyxaras SA, Mehilli J, Caramanno G, Di Mario C, Brugaletta S, Weber J, Capranzano P, Sabate M, Mattesini A, Geraci S, Naber CK, Araszkiewicz A, Colombo A, Tamburino C, Nef H, Münzel T.

EuroIntervention. 2016 Aug 5;12(5):e550-6. doi: 10.4244/EIJY15M09_10.

PMID: 26348681

62. Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study.

Naber CK, Pyxaras SA, Nef H, IJsselmuiden AJ, Briguori C, Schlundt C, Wykrzykowska J, Eberli FR, Möllmann H, Galatius S, Rieber J, Commeau P, van Geuns RJ, Bouchez D, Mudra H.

EuroIntervention. 2016 Jun 20;12(3):356-8. doi: 10.4244/EIJY15M06_02.

PMID: 26060087

63. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.

Tamburino C, Capranzano P, Gori T, Latib A, Lesiak M, Nef H, Caramanno G, Naber C, Mehilli J, Di Mario C, Sabaté M, Münzel T, Colombo A, Araszkiewicz A, Wiebe J, Geraci S, Jensen C, Mattesini A, Brugaletta S, Capodanno D.

JACC Cardiovasc Interv. 2016 Mar 14;9(5):440-9. doi: 10.1016/j.jcin.2015.10.042. Epub 2016 Jan 6.

PMID: 26875648

64. Transapical valve-in-valve TAVI in a patient with two failing surgical bioprostheses with Edwards SAPIEN 3 valves using a cerebral protection system.

Wolf A, Schmitz T, Bigdeli H, Naber CK.

EuroIntervention. 2016 Mar;11(12):1432. doi: 10.4244/EIJV11I12A274.

PMID: 26999683 No abstract available.

65. Real-world multicentre experience with the Direct Flow Medical repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis.

Naber CK, Pyxaras SA, Ince H, Latib A, Frambach P, den Heijer P, Wagner D, Butter C, Colombo A, Kische S.

EuroIntervention. 2016 Feb;11(11):e1314-20. doi: 10.4244/EIJV11I11A254.

PMID: 26865450

66. Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: Rationale and design of the German-Austrian ABSORB RegIstRy (GABI-R).

Nef H, Wiebe J, Achenbach S, Münzel T, Naber C, Richardt G, Mehilli J, Wöhrle J, Neumann T, Biermann J, Zahn R, Kastner J, Schmermund A, Pfannebecker T, Schneider S, Limbourg T, Hamm CW.

Cardiovasc Revasc Med. 2016 Jan-Feb;17(1):34-7. doi: 10.1016/j.carrev.2015.09.002. Epub 2015 Sep 10.

PMID: 26431767

67. Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.

Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrié D, Naber C, Lipiecki J, Richardt G, Iñiguez A, Brunel P, Valdes-Chavarri M, Garot P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahari R, Gregson J, Greene S, Stoll HP, Morice MC; LEADERS FREE Investigators.

N Engl J Med. 2015 Nov 19;373(21):2038-47. doi: 10.1056/NEJMoa1503943. Epub 2015 Oct 14.

PMID: 26466021 Clinical Trial.

68. Effect of Varying Definitions of Contrast-Induced Acute Kidney Injury and Left Ventricular Ejection Fraction on One-Year Mortality in Patients Having Transcatheter Aortic Valve Implantation.

Pyxaras SA, Zhang Y, Wolf A, Schmitz T, Naber CK.

Am J Cardiol. 2015 Aug 1;116(3):426-30. doi: 10.1016/j.amjcard.2015.04.056. Epub 2015 May 8.

PMID: 26026866

69. Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality.

Zhang Y, Pyxaras SA, Wolf A, Schmitz T, Naber CK.

Catheter Cardiovasc Interv. 2015 Jun;85(7):1217-25. doi: 10.1002/ccd.25831. Epub 2015 Feb 3.

PMID: 25581785

70. Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds.

Wöhrle J, Naber C, Schmitz T, Schwencke C, Frey N, Butter C, Brachmann J, Ingwersen M, Drabik A, Markovic S, Mathey DG.

EuroIntervention. 2015 Jun;11(2):149-56. doi: 10.4244/EIJY14M12_10.

PMID: 25499836

71. Reduction of QTD--A Novel Marker of Successful Reperfusion in NSTEMI. Pathophysiologic Insights by CMR.

Jensen CJ, Lusebrink S, Wolf A, Schlosser T, Nassenstein K, Naber CK, Sabin GV, Bruder O.

Int J Med Sci. 2015 May 3;12(5):378-86. doi: 10.7150/ijms.11224. eCollection 2015.

PMID: 26005372 Free PMC article.

72. Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective.

Tamburino C, Latib A, van Geuns RJ, Sabate M, Mehilli J, Gori T, Achenbach S, Alvarez MP, Nef H, Lesiak M, Di Mario C, Colombo A, Naber CK, Caramanno G, Capranzano P, Brugaletta S, Geraci S, Araszkiewicz A, Mattesini A, Pyxaras SA, Rzeszutko L, Depukat R, Diletti R, Boone E, Capodanno D, Dudek D.

EuroIntervention. 2015 May;11(1):45-52. doi: 10.4244/EIJY15M01_05.

PMID: 25599676

73. Randomized trial of primary PCI with or without routine manual thrombectomy.

Jolly SS, Cairns JA, Yusuf S, Meeks B, Pogue J, Rokoss MJ, Kedev S, Thabane L, Stankovic G, Moreno R, Gershlick A, Chowdhary S, Lavi S, Niemelä K, Steg PG, Bernat I, Xu Y, Cantor WJ, Overgaard CB, Naber CK, Cheema AN, Welsh RC, Bertrand OF, Avezum A, Bhindi R, Pancholy S, Rao SV, Natarajan MK, ten Berg JM, Shestakovska O, Gao P, Widimsky P, Džavík V; TOTAL Investigators.

N Engl J Med. 2015 Apr 9;372(15):1389-98. doi: 10.1056/NEJMoa1415098. Epub 2015 Mar 16.

PMID: 25853743 Free PMC article. Clinical Trial.

74. Successful repositioning of a direct flow medical 25-mm valve due to acute occlusion of right coronary artery during transcatheter aortic valve replacement procedure.

Wolf A, Schmitz T, Latib A, Naber CK.

JACC Cardiovasc Interv. 2015 Feb;8(2):e33-e34. doi: 10.1016/j.jcin.2013.11.030.

PMID: 25700765 No abstract available.

75. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.

Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C.

EuroIntervention. 2015 Feb;10(10):1144-53. doi: 10.4244/EIJY14M07_11.

PMID: 25042421

76. Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial.

Kaiser C, Galatius S, Jeger R, Gilgen N, Skov Jensen J, Naber C, Alber H, Wanitschek M, Eberli F, Kurz DJ, Pedrazzini G, Moccetti T, Rickli H, Weilenmann D, Vuillomenet A, Steiner M, Von Felten S, Vogt DR, Wadt Hansen K, Rickenbacher P, Conen D, Müller C, Buser P, Hoffmann A, Pfisterer M; BASKET-PROVE II study group.

Circulation. 2015 Jan 6;131(1):74-81. doi: 10.1161/CIRCULATIONAHA.114.013520. Epub 2014 Nov 19.

PMID: 25411159 Clinical Trial.

77. The STENTYS Self-Apposing® stent.

Pyxaras SA, Schmitz T, Naber CK.

EuroIntervention. 2015;11 Suppl V:V147-8. doi: 10.4244/EIJV11SVA34.

PMID: 25983152 No abstract available.

78. Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry.

Toelg R, Merkely B, Erglis A, Hoffman S, Bruno H, Kornowski R, Slagboom T, Naber C, Witzenbichler B, Graf K, Richardt G, Hehrlein C; DELUX investigators.

EuroIntervention. 2014 Sep;10(5):591-9. doi: 10.4244/EIJV10I5A102.

PMID: 24345357

79. Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections.

Welch M, Uslan DZ, Greenspon AJ, Sohail MR, Baddour LM, Blank E, Carrillo RG, Danik SB, Del Rio A, Hellinger W, Le KY, Miro JM, Naber C, Peacock JE, Vikram HR, Tseng CH, Prutkin JM; MEDIC Investigators.

Pacing Clin Electrophysiol. 2014 Aug;37(8):955-62. doi: 10.1111/pace.12385. Epub 2014 Mar 25.

PMID: 24665867

80. Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy).

Conrotto F, Scacciatella P, D'Ascenzo F, Chieffo A, Latib A, Park SJ, Kim YH, Onuma Y, Capranzano P, Jegere S, Makkar R, Palacios I, Buszman P, Chakravarty T, Mehran R, Naber C, Margey R, Leon M, Moses J, Fajadet J, Lefèvre T, Morice MC, Erglis A, Tamburino C, Alfieri O, D'Amico M, Marra S, Serruys PW, Colombo A, Meliga E.

Am J Cardiol. 2014 Jun 15;113(12):2007-12. doi: 10.1016/j.amjcard.2014.03.044. Epub 2014 Apr 1.

PMID: 24793677

81. Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry.

Greenspon AJ, Le KY, Prutkin JM, Sohail MR, Vikram HR, Baddour LM, Danik SB, Peacock J, Falces C, Miro JM, Naber C, Carrillo RG, Tseng CH, Uslan DZ.

JACC Cardiovasc Imaging. 2014 Jun;7(6):541-9. doi: 10.1016/j.jcmg.2014.01.015. Epub 2014 May 7.

PMID: 24813965

82. Unmet needs of young interventional cardiologists: proceedings from the 2nd summit of the European association of percutaneous cardiovascular interventions.

Capodanno D, Ducrocq G, Toth G, Dörler J, Iversen AZ, Dobric M, Schurtz G, Morice MC, Windecker S, Gonçalves L, Gilard M, Naber CK, Fajadet J.

EuroIntervention. 2014 May;10(1):47-9. doi: 10.4244/EIJV10I1A9.

PMID: 24832637

83. Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry).

Buchanan GL, Chieffo A, Meliga E, Mehran R, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar RR, Palacios IF, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Naber C, Margey R, Agnihotri A, Marra S, Capodanno D, Allgar V, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.

Am J Cardiol. 2014 Apr 15;113(8):1348-55. doi: 10.1016/j.amjcard.2014.01.409. Epub 2014 Jan 31.

PMID: 24581924 Clinical Trial.

84. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.

Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.

JACC Cardiovasc Interv. 2014 Apr;7(4):354-61. doi: 10.1016/j.jcin.2013.11.014. Epub 2014 Mar 14.

PMID: 24630886

85. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps).

Nørgaard BL, Leipsic J, Gaur S, Seneviratne S, Ko BS, Ito H, Jensen JM, Mauri L, De Bruyne B, Bezerra H, Osawa K, Marwan M, Naber C, Erglis A, Park SJ, Christiansen EH, Kaltoft A, Lassen JF, Bøtker HE, Achenbach S; NXT Trial Study Group.

J Am Coll Cardiol. 2014 Apr 1;63(12):1145-1155. doi: 10.1016/j.jacc.2013.11.043. Epub 2014 Jan 30.

PMID: 24486266 Clinical Trial.

86. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.

JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.

PMID: 24355114

87. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study.

Chirouze C, Athan E, Alla F, Chu VH, Ralph Corey G, Selton-Suty C, Erpelding ML, Miro JM, Olaison L, Hoen B; International Collaboration on Endocarditis Study Group.

Clin Microbiol Infect. 2013 Dec;19(12):1140-7. doi: 10.1111/1469-0691.12166. Epub 2013 Mar 20.

PMID: 23517406

88. Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry.

Meliga E, De Benedictis M, Chieffo A, Latib A, Park SJ, Kim YH, Onuma Y, Capranzano P, Jegere S, Makkar R, Palacios I, Buszman P, Bande M, Chakravarty T, Mehran R, Naber C, Scrocca I, Margey R, Leon M, Moses J, Fajadet J, Lefèvre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Conte MR, Serruys PW, Colombo A.

EuroIntervention. 2013 Nov;9(7):803-8. doi: 10.4244/EIJV9I7A133.

PMID: 24280156

89. Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry.

Akin I, Naber C, Sabin G, Hochadel M, Senges J, Kuck KH, Nienaber C, Richardt G, Tölg R.

Clin Res Cardiol. 2013 Sep;102(9):679-86. doi: 10.1007/s00392-013-0582-1. Epub 2013 May 17.

PMID: 23681360

90. Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry.

Abdel-Wahab M, Zahn R, Horack M, Gerckens U, Schuler G, Sievert H, Naber C, Voehringer M, Schäfer U, Senges J, Richardt G.

Clin Res Cardiol. 2012 Dec;101(12):973-81. doi: 10.1007/s00392-012-0486-5. Epub 2012 Jul 7.

PMID: 22772776

91. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.

Stella PR, Belkacemi A, Dubois C, Nathoe H, Dens J, Naber C, Adriaenssens T, van Belle E, Doevendans P, Agostoni P.

Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1138-46. doi: 10.1002/ccd.23499. Epub 2012 Mar 15.

PMID: 22422607 Clinical Trial.

92. Transatlantic perspectives on TAVI: from essential infrastructure and integration to expansion, research and development.

Prendergast BD, Naber CK, Popma JJ.

Heart. 2012 Nov;98 Suppl 4:iv37-43. doi: 10.1136/heartjnl-2012-302397.

PMID: 23143124 Review. No abstract available.

93. Age-stratified baseline and outcome characteristics of patients undergoing transcatheter aortic valve implantation: results from the German multicenter registry.

Buellesfeld L, Gerckens U, Erbel R, Zahn R, Linke A, Sievert H, Figulla HR, Kuck KH, Hauptmann KE, Hambrecht R, Richardt G, Naber C, Voehringer M, Mudra H, Senges J, Grube E; German TAVI Registry Investigators.

J Invasive Cardiol. 2012 Oct;24(10):531-6.

PMID: 23043037

94. Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial.

Hehrlein C, Dietz U, Kubica J, Jørgensen E, Hoffmann E, Naber C, Lesiak M, Schneider H, Wiemer M, Tölg R, Richardt G.

Cardiovasc Revasc Med. 2012 Sep-Oct;13(5):260-4. doi: 10.1016/j.carrev.2012.06.002. Epub 2012 Aug 4.

PMID: 22867706 Clinical Trial.

95. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.

Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Kim YH, Buszman PE, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capodanno D, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.

JACC Cardiovasc Interv. 2012 Jul;5(7):718-27. doi: 10.1016/j.jcin.2012.03.022.

PMID: 22814776

96. Tools & Techniques: the year of the Textbook - time to say good-bye!

Naber CK, Sachdev B, Muller O, Eeckhout E, Fajadet J.

EuroIntervention. 2012 May 15;8(1):164-5. doi: 10.4244/EIJV8I1A24.

PMID: 22580260 No abstract available.

97. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.

Naber CK, Ghanem A, Abizaid AA, Wolf A, Sinning JM, Werner N, Nickenig G, Schmitz T, Grube E.

EuroIntervention. 2012 May 15;8(1):43-50. doi: 10.4244/EIJV8I1A8.

PMID: 22403768

98. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices.

Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber C, Miró JM, Ninot S, Fernández-Hidalgo N, Durante-Mangoni E, Spelman D, Hoen B, Lejko-Zupanc T, Cecchi E, Thuny F, Hannan MM, Pappas P, Henry M, Fowler VG Jr, Crowley AL, Wang A; ICE-PCS Investigators.

JAMA. 2012 Apr 25;307(16):1727-35. doi: 10.1001/jama.2012.497.

PMID: 22535857

99. ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease.

Rosenhek R, Iung B, Tornos P, Antunes MJ, Prendergast BD, Otto CM, Kappetein AP, Stepinska J, Kaden JJ, Naber CK, Acartürk E, Gohlke-Bärwolf C.

Eur Heart J. 2012 Apr;33(7):822-8, 828a, 828b. doi: 10.1093/eurheartj/ehr061. Epub 2011 Mar 15.

PMID: 21406443 Free PMC article.

100. An interdisciplinary debate initiated by the European Society of Cardiology Working Group on Valvular Heart Disease.

Naber CK, Prendergast B, Thomas M, Vahanian A, Iung B, Rosenhek R, Tornos P, Otto CM, Antunes MJ, Kappetein P, Lange R, Wendler O.

EuroIntervention. 2012 Mar;7(11):1257-74. doi: 10.4244/EIJV7I11A201.

PMID: 22433190 No abstract available.

101. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort).

Greenspon AJ, Prutkin JM, Sohail MR, Vikram HR, Baddour LM, Danik SB, Peacock J, Falces C, Miro JM, Blank E, Naber C, Carrillo RG, Tseng CH, Uslan DZ.

J Am Coll Cardiol. 2012 Feb 14;59(7):681-7. doi: 10.1016/j.jacc.2011.11.011.

PMID: 22322085

102. Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design.

Jeger R, Pfisterer M, Alber H, Eberli F, Galatius S, Naber C, Pedrazzini G, Rickli H, Jensen JS, Vuilliomenet A, Gilgen N, Kaiser C.

Am Heart J. 2012 Feb;163(2):136-41.e1. doi: 10.1016/j.ahj.2011.08.023.

PMID: 22305828 Clinical Trial.

103. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.

Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A.

JAMA. 2011 Nov 23;306(20):2239-47. doi: 10.1001/jama.2011.1701.

PMID: 22110106 Free PMC article.

104. [Antibiotic prophylaxis in urology].

Wagenlehner FM, Grabe M, Naber KG, Bjerklund Johansen TE, Naber CK, Weidner W.

Urologe A. 2011 Nov;50(11):1469-78; quiz 1479-80. doi: 10.1007/s00120-011-2661-0.

PMID: 21997660 German.

105. Echocardiography versus intracardiac electrocardiography-based optimization for cardiac resynchronization therapy : a comparative clinical long-term trial.

Jensen CJ, Liadski A, Bell M, Naber CK, Bruder O, Sabin GV, Küpper B, Wieneke H.

Herz. 2011 Oct;36(7):592-9. doi: 10.1007/s00059-011-3507-7.

PMID: 21922233 Clinical Trial.

106. Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI.

Jensen CJ, Eberle HC, Nassenstein K, Schlosser T, Farazandeh M, Naber CK, Sabin GV, Bruder O.

Clin Res Cardiol. 2011 Aug;100(8):649-59. doi: 10.1007/s00392-011-0290-7. Epub 2011 Feb 24.

PMID: 21347741

107. Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study.

Grube E, Naber C, Abizaid A, Sousa E, Mendiz O, Lemos P, Kalil Filho R, Mangione J, Buellesfeld L.

JACC Cardiovasc Interv. 2011 Jul;4(7):751-7. doi: 10.1016/j.jcin.2011.03.015.

PMID: 21777882 Clinical Trial.

108. Interdisciplinary treatment for vestibular dysfunction: the effectiveness of mindfulness, cognitive-behavioral techniques, and vestibular rehabilitation.

Naber CM, Water-Schmeder O, Bohrer PS, Matonak K, Bernstein AL, Merchant MA.

Otolaryngol Head Neck Surg. 2011 Jul;145(1):117-24. doi: 10.1177/0194599811399371.

PMID: 21493331

109. Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis.

Hehrlein C, Richardt G, Wiemer M, Schneider H, Naber C, Hoffmann E, Dietz U.

EuroIntervention. 2011 May;7 Suppl K:K119-24. doi: 10.4244/EIJV7SKA20.

PMID: 22027721 Clinical Trial.

Hailer B, Naber C, Koslowski B, van Leeuwen P, Schäfer H, Budde T, Jacksch R, Sabin G, Erbel R; Myocardial Infarction Network Essen.

Clin Cardiol. 2011 May;34(5):294-301. doi: 10.1002/clc.20916.

PMID: 21557255 Free PMC article.

111. Population pharmacokinetics and penetration into prostatic, seminal, and vaginal fluid for ciprofloxacin, levofloxacin, and their combination.

Bulitta JB, Kinzig M, Naber CK, Wagenlehner FM, Sauber C, Landersdorfer CB, Sörgel F, Naber KG.

Chemotherapy. 2011;57(5):402-16. doi: 10.1159/000329520. Epub 2011 Oct 18.

PMID: 22024700 Clinical Trial.

112. Tools & Techniques: angiographic views.

Naber CK, Schmitz T, Meuter K, Sabin GV.

EuroIntervention. 2010 Aug;6(3):424-5. doi: 10.4244/EIJV6I3A70.

PMID: 20884425 No abstract available.

113. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias.

Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr, Corey GR, Chu VH, Fenely M, Pachirat O, Tan RS, Watkin R, Ionac A, Moreno A, Mestres CA, Casabé J, Chipigina N, Eisen DP, Spelman D, Delahaye F, Peterson G, Olaison L, Wang A; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators.

Circulation. 2010 Mar 2;121(8):1005-13. doi: 10.1161/CIRCULATIONAHA.109.864488. Epub 2010 Feb 16.

PMID: 20159831 Free PMC article.

114. Rapid MR assessment of left ventricular systolic function after acute myocardial infarction using single breath-hold cine imaging with the temporal parallel acquisition technique (TPAT) and 4D guide-point modelling analysis of left ventricular function.

Eberle HC, Nassenstein K, Jensen CJ, Schlosser T, Sabin GV, Naber CK, Bruder O.

Eur Radiol. 2010 Jan;20(1):73-80. doi: 10.1007/s00330-009-1522-3. Epub 2009 Jul 25.

PMID: 19633859

115. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.

Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL; ESC Committee for Practice Guidelines.

Eur Heart J. 2009 Oct;30(19):2369-413. doi: 10.1093/eurheartj/ehp285. Epub 2009 Aug 27.

PMID: 19713420 No abstract available.

116. A simple MR algorithm for estimation of myocardial salvage following acute ST segment elevation myocardial infarction.

Jensen CJ, Bleckmann D, Eberle HC, Nassenstein K, Schlosser T, Sabin GV, Naber CK, Bruder O.

Clin Res Cardiol. 2009 Oct;98(10):651-6. doi: 10.1007/s00392-009-0051-z. Epub 2009 Aug 14.

PMID: 19685002

117. Pioneers, teachers and students: the 'how-to' of cardiovascular interventions.

Sachdev B, Naber CK, Eeckhout E, Fajadet J.

EuroIntervention. 2009 Aug;5(3):285, 287.

PMID: 19736150 No abstract available.

118. Infective endocarditis--prophylaxis, diagnostic criteria, and treatment.

Westphal N, Plicht B, Naber C.

Dtsch Arztebl Int. 2009 Jul;106(28-29):481-9; quiz 490. doi: 10.3238/arztebl.2009.0481. Epub 2009 Jul 13.

PMID: 19730718 Free PMC article. Review.

119. [Renal artery stenosis. Pathophysiology--diagnosis--therapy].

Wieneke H, Konorza TF, Eggebrecht H, Naber CK, Philipp S, Philipp T, Kribben A, Erbel R.

Med Klin (Munich). 2009 May 15;104(5):349-55. doi: 10.1007/s00063-009-1073-z. Epub 2009 May 16.

PMID: 19444415 Review. German.

120. Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus.

Naber CK, Baddour LM, Giamarellos-Bourboulis EJ, Gould IM, Herrmann M, Hoen B, Karchmer AW, Kobayashi Y, Kozlov RS, Lew D, Miró JM, Moellering RC Jr, Moreillon P, Peters G, Rubinstein E, Seifert H, Corey GR.

Clin Infect Dis. 2009 May 15;48 Suppl 4:S260-70. doi: 10.1086/598185.

PMID: 19374582

121. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies.

Naber CK.

Clin Infect Dis. 2009 May 15;48 Suppl 4:S231-7. doi: 10.1086/598189.

PMID: 19374578

122. Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid.

Eisen DP, Corey GR, McBryde ES, Fowler VG Jr, Miro JM, Cabell CH, Street AC, Paiva MG, Ionac A, Tan RS, Tribouilloy C, Pachirat O, Jones SB, Chipigina N, Naber C, Pan A, Ravasio V, Gattringer R, Chu VH, Bayer AS; ICE Investigators.

J Infect. 2009 May;58(5):332-8. doi: 10.1016/j.jinf.2009.03.006. Epub 2009 Mar 20.

PMID: 19342103

123. Impact of admission blood glucose on outcomes of nondiabetic patients with acute ST-elevation myocardial infarction (from the German Acute Coronary Syndromes [ACOS] Registry).

Naber CK, Mehta RH, Jünger C, Zeymer U, Wienbergen H, Sabin GV, Erbel R, Senges J, Gitt A.

Am J Cardiol. 2009 Mar 1;103(5):583-7. doi: 10.1016/j.amjcard.2008.11.005. Epub 2009 Jan 17.

PMID: 19231316

124.

Systematic analysis of functional and structural changes after coronary microembolization: a cardiac magnetic resonance imaging study.

Breuckmann F, Nassenstein K, Bucher C, Konietzka I, Kaiser G, Konorza T, Naber C, Skyschally A, Gres P, Heusch G, Erbel R, Barkhausen J.

JACC Cardiovasc Imaging. 2009 Feb;2(2):121-30. doi: 10.1016/j.jcmg.2008.10.011.

PMID: 19356544

125. Angina during upper limb exercise: pathognomonic clinical feature of coronary-subclavian steal syndrome?

Malyar NM, Naber C, Erbel R.

BMJ Case Rep. 2009;2009:bcr2006096487. doi: 10.1136/bcr.2006.096487. Epub 2009 Feb 16.

PMID: 21687144 Free PMC article. No abstract available.

126. Proceedings of the 3rd International Conference on Bloodstream Infections. Introduction.

Scaglione F, Naber C.

Int J Antimicrob Agents. 2009;34 Suppl 4:S1. doi: 10.1016/S0924-8579(09)00501-9.

PMID: 19931808 No abstract available.

127. Recurrent infective endocarditis with uncommon Gram-negative Pasteurella multocida and Pseudomonas aeruginosa: a case report.

Reinsch N, Plicht B, Lind A, Jánosi RA, Buck T, Kamler M, Jakob H, Naber CK, Erbel R.

J Heart Valve Dis. 2008 Nov;17(6):710-3.

PMID: 19137805

128. [Therapy and prophylaxis of infective endocarditis].

Plicht B, Naber CK, Erbel R.

Internist (Berl). 2008 Oct;49(10):1219-27; quiz 1228-9. doi: 10.1007/s00108-008-2205-x.

PMID: 18791693 German.

129. Commentary on endocarditis prophylaxis: a quaint custom or medical necessity?

Prendergast BD, Harrison JL, Naber CK.

Heart. 2008 Jul;94(7):931-4. doi: 10.1136/hrt.2008.145391.

PMID: 18552227 Review. No abstract available.

130. Methods to evaluate the pharmacology of oral antiplatelet drugs.

Weber AA, Adamzik M, Bachmann HS, Görlinger K, Grandoch M, Leineweber K, Müller-Beissenhirtz H, Wenzel F, Naber C; Interdisciplinary Study Group - Clinical Pharmacology of Haemostasis.

Herz. 2008 Jun;33(4):287-96. doi: 10.1007/s00059-008-3132-2.

PMID: 18581078 Review.

131. Membrane environment rather than tissue factor expression determines thrombin formation triggered by monocytic cells undergoing apoptosis.

Stampfuss JJ, Censarek P, Bein D, Schrör K, Grandoch M, Naber C, Weber AA.

J Leukoc Biol. 2008 Jun;83(6):1379-81. doi: 10.1189/jlb.1207843. Epub 2008 Feb 27.

PMID: 18305177

132. Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly.

Sack S, Kahlert P, Khandanpour S, Naber C, Philipp S, Möhlenkamp S, Sievers B, Kälsch H, Erbel R.

Clin Res Cardiol. 2008 May;97(5):288-97. doi: 10.1007/s00392-008-0650-0. Epub 2008 Apr 3.

PMID: 18389165

133. [STEMI network Essen--results after 1 year].

Hailer B, Naber CK, Koslowski B, Budde T, Jacksch R, Sabin G, Lange S, Erbel R; Herzinfarktverbund Essen.

Herz. 2008 Mar;33(2):153-7. doi: 10.1007/s00059-008-3091-7.

PMID: 18344036 German.

134. [STEMI network Essen-in-hospital results].

Buchholz J, Naber CK, Budde T, Koslowski B, Hailer B, Jacksch R, Sabin G, Haude M, Erbel R; für den Herzinfarktverbund Essen.

Herz. 2008 Mar;33(2):148-52. doi: 10.1007/s00059-008-3119-z.

PMID: 18344035 German.

135. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".

Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV; Herzinfarktverbund Essen.

Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8.

PMID: 18344033

136. [Primary Coronary Intervention (PCI) within the myocardial infarction network system in a German city (Essen)].

Jacksch R, Naber CK, Koslowski B, Budde T, Hailer B, Sabin G, Haude M, Wald C, Erbel R; Herzinfarktverbund Essen.

Herz. 2008 Mar;33(2):110-4. doi: 10.1007/s00059-008-3098-0.

PMID: 18344029 German.

137. Future strategies for treating Staphylococcus aureus bloodstream infections.

Naber CK.

Clin Microbiol Infect. 2008 Mar;14 Suppl 2:26-34. doi: 10.1111/j.1469-0691.2008.01924.x.

PMID: 18226087 Review.

138. [Methods to evaluate aspirin and clopidogrel resistance].

Weber AA, Adamzik M, Bachmann HS, Görlinger K, Grandoch M, Leineweber K, Müller-Beissenhirtz H, Wenzel F, Naber C; für die interdisziplinäre Studiengruppe Clinical Pharmacology of Haemostasis.

Hamostaseologie. 2008 Feb;28(1-2):66-71.

PMID: 18278165 Review. German.

139. [New health care delivery model in cardiology -- Myocardial Infarction Network Essen].

Bruder O, Naber CK, Grosch B, Koslowski B, Benesch L, Budde T, Hailer B, Jacksch R, Erbel R, Sabin G; Herzinfarktverbund Essen.

Herz. 2007 Dec;32(8):630-4. doi: 10.1007/s00059-007-3068-y.

PMID: 18060609 Review. German.

140. Infective endocarditis with negative blood cultures.

Naber CK, Erbel R.

Int J Antimicrob Agents. 2007 Nov;30 Suppl 1:S32-6. doi: 10.1016/j.ijantimicag.2007.07.017. Epub 2007 Sep 24.

PMID: 17890062 Review.

141. New guidelines for infective endocarditis: a call for collaborative research.

Naber CK, Erbel R, Baddour LM, Horstkotte D.

Int J Antimicrob Agents. 2007 Jun;29(6):615-6. doi: 10.1016/j.ijantimicag.2007.01.016. Epub 2007 Mar 29.

PMID: 17398075 No abstract available.

142. Contemporary clinical profile and outcome of prosthetic valve endocarditis.

Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Paré C, Almirante B, Muñoz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Jones SB, Casabé J, Morris A, Corey GR, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study Investigators.

JAMA. 2007 Mar 28;297(12):1354-61. doi: 10.1001/jama.297.12.1354.

PMID: 17392239

143. [Assessment of the natural history of coronary artery calcification and identification of its determinants. Rationale of the 2nd part of the Heinz Nixdorf Recall Study].

Möhlenkamp S, Moebus S, Schmermund A, Lehmann N, Hoffmann B, Neumann T, Stang A, Dragano N, Kerkhoff G, Naber C, Kälsch H, Beck EM, Bröcker-Preuss M, Kröger K, Budde T, Siegrist J, Mann K, Jöckel KH, Erbel R; für die Studiengruppe der Heinz Nixdorf Recall Studie.

Herz. 2007 Mar;32(2):108-20. doi: 10.1007/s00059-007-2982-3.

PMID: 17401753 German.

144. Angina during upper limb exercise: pathognomonic clinical feature of coronary-subclavian steal syndrome?

Malyar NM, Naber C, Erbel R.

Heart. 2007 Mar;93(3):308. doi: 10.1136/hrt.2006.096487.

PMID: 17322506 Free PMC article. No abstract available.

145. [Infective endocarditis. A case report as mirror of the guidelines].

Plicht B, Naber CK, Szabo AK, Erbel R.

Herz. 2006 Dec;31(9):865-70. doi: 10.1007/s00059-006-2936-1.

PMID: 17180649 Review. German.

146. Mitral valve endocarditis leading to acute myocardial and cerebellar infarction in a young adult.

Breuckmann F, Naber CK, Boese D, Lind A, Wieneke H, Barkhausen J, Erbel R.

Clin Res Cardiol. 2006 Dec;95(12):657-62. doi: 10.1007/s00392-006-0436-1. Epub 2006 Sep 8.

PMID: 16941082 No abstract available.

147. [Aortic valve stenosis: from valvuloplasty to percutaneous heart valve].

Sack S, Kahlert P, Khandanpour S, Kordish I, Budeus M, Naber C, Philipp S, Möhlenkamp S, Erbel R.

Herz. 2006 Oct;31(7):688-93. doi: 10.1007/s00059-006-2909-4.

PMID: 17072784 Review. German.

148. [Infectious endocarditis].

Naber CK, Erbel R.

Dtsch Med Wochenschr. 2006 Sep 22;131(38):2091-4. doi: 10.1055/s-2006-951336.

PMID: 16981081 Review. German. No abstract available.

149. Better identification of patients who benefit from implantable cardioverter defibrillators by genotyping the G protein beta3 subunit (GNB3) C825T polymorphism.

Wieneke H, Naber CN, Piaszek L, Sack S, Frey UH, Heusch G, Erbel R, Siffert W.

Basic Res Cardiol. 2006 Sep;101(5):447-51. doi: 10.1007/s00395-006-0600-9. Epub 2006 Jun 16.

PMID: 16783490

150. Post-interventional homocysteine levels: failure as a predictive biomarker of in-stent restenosis.

Breuckmann F, Naber C, Beckert J, Schmermund A, Haude M, Baumgart D, Erbel R.

Int J Cardiol. 2006 Mar 22;108(1):20-5. doi: 10.1016/j.ijcard.2005.03.059.

PMID: 16516694

151. Relevance of the NOS3 T-786C and G894T variants for cholinergic and adrenergic coronary vasomotor responses in man.

Naber ChK, Frey UH, Oldenburg O, Brauck K, Eggebrecht H, Schmermund A, Baumgart D, Erbel R, Siffert W, Heusch G.

Basic Res Cardiol. 2005 Sep;100(5):453-60. doi: 10.1007/s00395-005-0530-y. Epub 2005 Jul 20.

PMID: 16032374

152. [Coronary stents. From a simple idea to a medical high-tech device].

Wieneke H, Böse D, Haude M, Eggebrecht H, Konorza T, Naber C, Erbel R.

Med Klin (Munich). 2005 Aug 15;100(8):505-11. doi: 10.1007/s00063-005-1065-6.

PMID: 16096733 German.

153. [Percutaneous heart valve implantation in the aortic position].

Sack S, Naber C, Kahlert P, Malyar N, Gutersohn A, Eggebrecht H, Ley R, Jakob HG, Erbel R.

Herz. 2005 Aug;30(5):433-7. doi: 10.1007/s00059-005-2726-1.

PMID: 16132247 German. No abstract available.

154. [Echocardiography in the diagnosis of endocarditis: transthoracic or transesophageal?].

Naber CK, Plicht B, Eggebrecht H, Buck T, Erbel R.

Herz. 2005 May;30(3):234-40. doi: 10.1007/s00059-005-2692-7.

PMID: 15902375 Review. German.

155. Endovascular stent-graft treatment of aortic dissection: determinants of post-interventional outcome.

Eggebrecht H, Herold U, Kuhnt O, Schmermund A, Bartel T, Martini S, Lind A, Naber CK, Kienbaum P, Kühl H, Peters J, Jakob H, Erbel R, Baumgart D.

Eur Heart J. 2005 Mar;26(5):489-97. doi: 10.1093/eurheartj/ehi099. Epub 2005 Jan 26.

PMID: 15673541

156. Resistant hypertension in patients with chronic aortic dissection.

Eggebrecht H, Schmermund A, von Birgelen C, Naber CK, Bartel T, Wenzel RR, Erbel R.

J Hum Hypertens. 2005 Mar;19(3):227-31. doi: 10.1038/sj.jhh.1001800.

PMID: 15565176

157. [S2 guideline for infectious endocarditis].

Naber CK, Bauhofer A, Block M, Buerke M, Erbel R, Graninger W, Herrmann M, Horstkotte D, Kern P, Lode H, Mehlhorn U, Meyer J, Mügge A, Niebel J, Peters G, Shah PM, Werdan K.

MMW Fortschr Med. 2004 Dec 9;146(Suppl 3-4):123-35.

PMID: 15662902 Review. German.

158. [S2 Guideline for diagnosis and therapy of infectious endocarditis].

Naber CK; Paul-Ehrlich-Gesellschaft für Chemotherapie; Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung; Deutschen Gesellschaft für Thorax-, Herz- und Gefässchirurgie; Deutschen Gesellschaft für Infektiologie; Deutschen Gesellschaft für Internistische Intensivmedizin und Notfallmedizin; Deutschen Gesellschaft für Hygiene und Mikrobiologie.

Z Kardiol. 2004 Dec;93(12):1005-21. doi: 10.1007/s00392-004-0183-0.

PMID: 15599576 German. No abstract available.

159. Analysis of fossa ovalis membrane velocities by transesophageal Doppler tissue echocardiography: a novel approach to functional assessment of patent foramen ovale.

Eggebrecht H, Naber CK, Plato C, Erbel R, Bartel T.

J Am Soc Echocardiogr. 2004 Nov;17(11):1161-6. doi: 10.1016/j.echo.2004.06.024.

PMID: 15502790

160. Acute and long-term outcome after coronary artery perforation during percutaneous coronary interventions.

Eggebrecht H, Ritzel A, von Birgelen C, Schermund A, Naber C, Böse D, Baumgart D, Bartel T, Haude M, Erbel R.

Z Kardiol. 2004 Oct;93(10):791-8. doi: 10.1007/s00392-004-0123-z.

PMID: 15492894

161. Genetics of human arterial hypertension.

Naber CK, Siffert W.

Minerva Med. 2004 Oct;95(5):347-56.

PMID: 15467511 Review.

162. Value of plasma fibrin D-dimers for detection of acute aortic dissection.

Eggebrecht H, Naber CK, Bruch C, Kröger K, von Birgelen C, Schmermund A, Wichert M, Bartel T, Mann K, Erbel R.

J Am Coll Cardiol. 2004 Aug 18;44(4):804-9. doi: 10.1016/j.jacc.2004.04.053.

PMID: 15312863

163. Impact of gender on femoral access complications secondary to application of a collagen-based vascular closure device.

Eggebrecht H, von Birgelen C, Naber C, Kröger K, Schmermund A, Wieneke H, Bartel T, Wörtgen U, Baumgart D, Haude M, Erbel R.

J Invasive Cardiol. 2004 May;16(5):247-50.

PMID: 15152129

164. Genetics of human coronary vasomotion.

Naber CK, Siffert W, Erbel R, Heusch G.

Arch Mal Coeur Vaiss. 2004 Mar;97(3):255-60.

PMID: 15106749 Review.

165. [Percutaneous coil embolization of a large, congenital coronary-pulmonary fistula using hydrophilic-coated detachable platinum coils].

Naber CK, Doerfler A, Churzidze S, Böse D, Schmermund A, Erbel R.

Herz. 2004 Mar;29(2):218-9. doi: 10.1007/s00059-004-2566-4.

PMID: 15057443 German. No abstract available.

166. Successful reduction of in-stent restenosis in long lesions using beta-radiation--subanalysis from the RENO registry.

Baumgart D, Bonan R, Naber C, Serruys P, Colombo A, Silber S, Eeckhout E, Urban P.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):817-27. doi: 10.1016/S0360-3016(03)01615-8.

PMID: 14967439

167. Intracoronary brachytherapy, a promising treatment option for diabetic patients: Results from a European multicenter registry (RENO).

Naber CK, Baumgart D, Bonan R, Wegscheider K, Serruys PW, Colombo A, Silber S, Eeckhout E, Eggebrecht H, Erbel R, Urban P.

Catheter Cardiovasc Interv. 2004 Feb;61(2):173-8. doi: 10.1002/ccd.10795.

PMID: 14755807

168. Role of the eNOS Glu298Asp variant on the GNB3825T allele dependent determination of alpha-adrenergic coronary constriction.

Naber CK, Baumgart D, Heusch G, Siffert W, Oldenburg O, Huesing J, Erbel R.

Pharmacogenetics. 2003 May;13(5):279-84. doi: 10.1097/00008571-200305000-00007.

PMID: 12724620

169. Percutaneous suture-mediated closure of femoral access sites deployed through the procedure sheath: initial clinical experience with a novel vascular closure device.

Eggebrecht H, Naber C, Woertgen U, Ringe S, Konorza TF, Schmermund A, von Birgelen C, Haude M, Kroeger K, Erbel R, Baumgart D.

Catheter Cardiovasc Interv. 2003 Mar;58(3):313-21. doi: 10.1002/ccd.10472.

PMID: 12594694

170. Diagnosis of culture negative endocarditis: novel strategies to prove the suspect guilty.

Naber CK, Erbel R.

Heart. 2003 Mar;89(3):241-3. doi: 10.1136/heart.89.3.241.

PMID: 12591812 Free PMC article. No abstract available.

171. [Brachytherapy after coronary interventions: current state and future perspectives].

Naber CK, Kaiser CA, Sauerwein W, Meusers P, Eggebrecht H, Haude M, Erbel R, Baumgart D.

Z Kardiol. 2003 Jan;92(1):1-15. doi: 10.1007/s00392-003-0843-5.

PMID: 12545296 Review. German.

172. Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients.

Eggebrecht H, Haude M, Woertgen U, Schmermund A, von Birgelen C, Naber C, Baumgart D, Kaiser C, Oldenburg O, Bartel T, Kroeger K, Erbel R.

Catheter Cardiovasc Interv. 2002 Dec;57(4):486-95. doi: 10.1002/ccd.10254.

PMID: 12455083

173. The human G protein beta 3 subunit GNB3 825T polymorphism.

Naber CK, Baumgart D, Erbel R.

Eur Heart J. 2002 May;23(10):830. doi: 10.1053/euhj.2002.3014.

PMID: 12066759 No abstract available.

174. Extraction of large intracoronary thrombus in acute myocardial infarction by percutaneous Fogarty maneuver: intentional abuse of a novel interventional device.

Eggebrecht H, Baumgart D, Naber C, Dirsch O, Haude M, Erbel R.

Catheter Cardiovasc Interv. 2002 Feb;55(2):228-32. doi: 10.1002/ccd.10050.

PMID: 11835653

175. Dose finding in intracoronary brachytherapy--consequences from empirical trials.

Baumgart D, Sauerwein W, Naber C, Meusers P, Quast U, Eggebrecht H, Erbel R.

Z Kardiol. 2002;91 Suppl 3:23-30. doi: 10.1007/s00392-002-1304-2.

PMID: 12641012 Review.

176. Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers.

Naber CK, Hammer M, Kinzig-Schippers M, Sauber C, Sörgel F, Bygate EA, Fairless AJ, Machka K, Naber KG.

Antimicrob Agents Chemother. 2001 Dec;45(12):3524-30. doi: 10.1128/AAC.45.12.3524-3530.2001.

PMID: 11709334 Free PMC article. Clinical Trial.

177. eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia.

Naber CK, Baumgart D, Altmann C, Siffert W, Erbel R, Heusch G.

Am J Physiol Heart Circ Physiol. 2001 Nov;281(5):H1908-12. doi: 10.1152/ajpheart.2001.281.5.H1908.

PMID: 11668050

178. The influence of guiding equipment and stents on the beta dose distribution in the brachytherapy of in-stent restenosis.

Flühs D, Wilke C, Naber C, Hienz M, Bambynek M, Kaiser C, Langner I, Baumgart D, Sauerwein W, Wegener D, Quast U.

Cardiovasc Radiat Med. 2001 Oct-Dec;2(4):241-5. doi: 10.1016/s1522-1865(01)00093-2.

PMID: 12160766

179. [Surgical treatment of infective endocarditis: the Essen experiences].

Herold U, Piotrowski J, van de Wal H, Kamler M, Yildirim C, Naber C, Erbel R, Jakob H.

Herz. 2001 Sep;26(6):409-17. doi: 10.1007/pl00002044.

PMID: 11683071 German.

180. [Diagnosis of endocarditis today: Duke criteria or clinical judgment?].

Naber CK, Bartel T, Eggebrecht H, Erbel R.

Herz. 2001 Sep;26(6):379-90. doi: 10.1007/pl00002042.

PMID: 11683068 Review. German.

181. Early clinical experience with the 6 French Angio-Seal device: immediate closure of femoral puncture sites after diagnostic and interventional coronary procedures.

Eggebrecht H, Haude M, von Birgelen C, Woertgen U, Schmermund A, Baumgart D, Kaiser C, Naber CK, Kroeger K, Erbel R.

Catheter Cardiovasc Interv. 2001 Aug;53(4):437-42. doi: 10.1002/ccd.1198.

PMID: 11514989

182. [Late stent thrombosis after intracoronary brachytherapy. A case report and review of the literature].

Naber CK, Kaiser CA, Rahman YA, Haude M, Erbel R, Baumgart D.

Z Kardiol. 2001 Feb;90(2):138-43. doi: 10.1007/s003920170201.

PMID: 11263004 German.

183. Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers.

Naber CK, Steghafner M, Kinzig-Schippers M, Sauber C, Sörgel F, Stahlberg HJ, Naber KG.

Antimicrob Agents Chemother. 2001 Jan;45(1):293-7. doi: 10.1128/AAC.45.1.293-297.2001.

PMID: 11120980 Free PMC article. Clinical Trial.

184. Dose-dependent effects of intracoronary verapamil on systemic and coronary hemodynamics.

Oldenburg O, Eggebrecht H, Herrmann J, Naber CK, Haude M, Erbel R, Baumgart D.

Cardiovasc Drugs Ther. 2000 Dec;14(6):651-5. doi: 10.1023/a:1007823116491.

PMID: 11300366 Clinical Trial.

185. Interaction of the ACE D allele and the GNB3 825T allele in myocardial infarction.

Naber CK, Hüsing J, Wolfhard U, Erbel R, Siffert W.

Hypertension. 2000 Dec;36(6):986-9. doi: 10.1161/01.hyp.36.6.986.

PMID: 11116112

186. Percutaneous transluminal laser guide wire recanalization of chronic subclavian artery occlusion in symptomatic coronary-subclavian steal syndrome.

Eggebrecht H, Naber CK, Oldenburg O, Herrmann J, Haude M, Erbel R, Baumgart D.

Catheter Cardiovasc Interv. 2000 Dec;51(4):500-4. doi: 10.1002/1522-726x(200012)51:4<500::aid-ccd28>3.0.co;2-t.

PMID: 11108691

187. Enhanced epinephrine-induced platelet aggregation in individuals carrying the G protein beta3 subunit 825T allele.

Naber C, Hermann BL, Vietzke D, Altmann C, Haude M, Mann K, Rosskopf D, Siffert W.

FEBS Lett. 2000 Nov 10;484(3):199-201. doi: 10.1016/s0014-5793(00)02158-x.

PMID: 11078878

188. G protein beta3 subunit 825 TT genotype and post-pregnancy weight retention.

Gutersohn A, Naber C, Müller N, Erbel R, Siffert W.

Lancet. 2000 Apr 8;355(9211):1240-1. doi: 10.1016/S0140-6736(00)02093-6.

PMID: 10770309

189. G protein beta3 subunit 825T allele and enhanced coronary vasoconstriction on alpha(2)-adrenoceptor activation.

Baumgart D, Naber C, Haude M, Oldenburg O, Erbel R, Heusch G, Siffert W.

Circ Res. 1999 Nov 12;85(10):965-9. doi: 10.1161/01.res.85.10.965.

PMID: 10559144

190. Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals.

Siffert W, Forster P, Jöckel KH, Mvere DA, Brinkmann B, Naber C, Crookes R, Du P Heyns A, Epplen JT, Fridey J, Freedman BI, Müller N, Stolke D, Sharma AM, Al Moutaery K, Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B, Du Toit ED, Tiilikainen A, Ge J, Wang Y, Rosskopf D, et al.

J Am Soc Nephrol. 1999 Sep;10(9):1921-30. doi: 10.1681/ASN.V1091921.

PMID: 10477144

191. G protein beta3 subunit 825T allele and its potential association with obesity in hypertensive individuals.

Siffert W, Naber C, Walla M, Ritz E.

J Hypertens. 1999 Aug;17(8):1095-8. doi: 10.1097/00004872-199917080-00008.

PMID: 10466464

Publikationen Dr. Christoph K. Naber